z-logo
Premium
Hepatitis C and G viruses in B‐cell lymphomas of the skin
Author(s) -
Michaelis Sonja,
Kazakov Dmitry V.,
Schmid Mirka,
Dummer Reinhard,
Burg Günter,
Kempf Werner
Publication year - 2003
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1034/j.1600-0560.2003.00083.x
Subject(s) - pathogenesis , lymphoproliferative disorders , virology , hepatitis c , medicine , b cell , hepatitis c virus , polymerase chain reaction , lymphoma , pathology , biology , immunology , virus , antibody , gene , genetics
Background:  The etiology of B‐cell lymphoproliferative disorders (LPDs) of the skin has still to be elucidated. So far, Borrelia sp. has been identified as the causative agent of some cases of B‐cell LPDs of the skin. Apart from bacterial pathogens, recent studies suggested that also flaviviruses, in particular hepatitis C (HCV) and G (HGV) viruses, may be involved in the pathogenesis of B‐cell non‐Hodgkin's lymphomas (NHLs). Most studies were performed in patients with known HCV infection, but the overall frequency of HCV‐ and HGV‐RNA in tumoral tissue of primary cutaneous B‐cell lymphomas (CBCLs) is unknown. Methods:  We examined 23 tumor biopsies of various forms of CBCLs by reverse transcriptase‐polymerase chain reaction (RT‐PCR) and sequencing for the presence of HCV and HGV. Results:  HCV‐RNA sequences were detected in seven of 23 (30%) of the tumor biopsies. In contrast, RNA sequences of HGV were not detected in any of the tumors. Conclusions:  Interestingly, the presence of HCV in our series of primary CBCLs was not restricted to a distinct clinicopathologic subform. HCV which can infect B cells, may play a role in pathogenesis of one‐third of CBCLs, whereas HGV is not involved in CBCLs. Further molecular studies and therapeutic trials are needed to clarify the putative pathogenetic role of HCV in CBCLs.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here